Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$40.26 - $57.37 $488,273 - $695,783
-12,128 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$54.88 - $79.29 $45,221 - $65,334
-824 Reduced 6.36%
12,128 $689,000
Q1 2021

May 06, 2021

SELL
$70.65 - $96.76 $543,157 - $743,890
-7,688 Reduced 37.25%
12,952 $969,000
Q4 2020

Feb 09, 2021

SELL
$58.41 - $89.06 $257,237 - $392,220
-4,404 Reduced 17.59%
20,640 $1.79 Million
Q3 2020

Nov 09, 2020

BUY
$41.13 - $62.45 $81,807 - $124,213
1,989 Added 8.63%
25,044 $1.53 Million
Q2 2020

Aug 04, 2020

BUY
$25.95 - $43.15 $210,039 - $349,256
8,094 Added 54.1%
23,055 $959,000
Q1 2020

May 06, 2020

SELL
$26.15 - $77.24 $128,291 - $378,939
-4,906 Reduced 24.69%
14,961 $430,000
Q4 2019

Feb 11, 2020

BUY
$60.18 - $154.77 $1.05 Million - $2.71 Million
17,483 Added 733.35%
19,867 $1.43 Million
Q3 2019

Nov 07, 2019

SELL
$140.29 - $189.96 $90,346 - $122,334
-644 Reduced 21.27%
2,384 $334,000
Q2 2019

Jul 25, 2019

BUY
$157.85 - $183.09 $477,969 - $554,396
3,028 New
3,028 $554,000
Q4 2018

Feb 12, 2019

SELL
$81.94 - $139.71 $203,702 - $347,319
-2,486 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$138.11 - $169.04 $343,341 - $420,233
2,486 New
2,486 $351,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $395M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.